ALX ONCOLOGY HOLDINGS INC Earnings Per Share (Diluted)
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Earnings Per Share (Diluted) of -$0.13 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for the quarter ending 2026-06-30 was -$0.13.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for the quarter ending 2026-03-31 was -$0.17.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for the quarter ending 2025-12-31 was -$0.42.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for the quarter ending 2025-09-30 was -$0.41.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for fiscal 2025 was -$1.90.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for fiscal 2024 was -$2.58.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for fiscal 2023 was -$3.74.
- ALX ONCOLOGY HOLDINGS INC earnings per share, diluted for fiscal 2022 was -$3.03.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.13 10-Q · filed 2026-08-06 | -$0.30 10-Q · filed 2026-08-06 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2026-03-31 | -$0.17 10-Q · filed 2026-05-08 | -$0.51 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.34 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$1.32 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.90 10-K · filed 2026-03-09 |
| 2025-09-30 | -$0.41 10-Q · filed 2025-11-07 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.48 10-Q · filed 2025-11-07 | -$2.01 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-06-30 | -$0.49 10-Q · filed 2026-08-06 | -$1.05 10-Q · filed 2026-08-06 | -$1.60 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.18 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2025-03-31 | -$0.58 10-Q · filed 2026-05-08 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.45 derived: net income ÷ weighted average shares · filed 2026-08-06 |
| 2024-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$1.12 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$2.58 10-K · filed 2026-03-09 |
| 2024-09-30 | -$0.58 10-Q · filed 2025-11-07 | -$1.34 derived: net income ÷ weighted average shares · filed 2025-11-07 | -$2.05 10-Q · filed 2025-11-07 | -$2.97 derived: net income ÷ weighted average shares · filed 2026-04-20 |
| 2024-06-30 | -$0.76 10-Q · filed 2025-08-12 | -$1.47 10-Q · filed 2025-08-12 | -$2.39 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$3.57 derived: net income ÷ weighted average shares · filed 2026-04-20 |
| 2024-03-31 | -$0.71 10-Q · filed 2025-05-08 | -$1.63 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$2.82 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$3.67 derived: net income ÷ weighted average shares · filed 2026-04-20 |
| 2023-12-31 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$2.14 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$2.99 derived: net income ÷ weighted average shares · filed 2026-04-20 | -$3.74 10-K · filed 2026-03-09 |
| 2023-09-30 | -$1.24 10-Q · filed 2024-11-07 | -$2.08 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.82 10-Q · filed 2024-11-07 | -$3.57 derived: net income ÷ weighted average shares · filed 2025-03-06 |
| 2023-06-30 | -$0.84 10-Q · filed 2024-08-12 | -$1.57 10-Q · filed 2024-08-12 | -$2.33 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$3.19 derived: net income ÷ weighted average shares · filed 2025-03-06 |
| 2023-03-31 | -$0.74 10-Q · filed 2024-05-09 | -$1.49 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$2.36 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$3.17 derived: net income ÷ weighted average shares · filed 2025-03-06 |
| 2022-12-31 | -$0.75 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$1.62 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$2.43 derived: net income ÷ weighted average shares · filed 2025-03-06 | -$3.03 10-K · filed 2025-03-06 |
| 2022-09-30 | -$0.87 10-Q · filed 2023-11-13 | -$1.68 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$2.28 10-Q · filed 2023-11-13 | -$2.98 derived: net income ÷ weighted average shares · filed 2024-03-07 |
| 2022-06-30 | -$0.81 10-Q · filed 2023-08-10 | -$1.41 10-Q · filed 2023-08-10 | -$2.11 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$2.72 derived: net income ÷ weighted average shares · filed 2024-03-07 |
| 2022-03-31 | -$0.60 10-Q · filed 2023-05-11 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.91 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$2.32 derived: net income ÷ weighted average shares · filed 2024-03-07 |
| 2021-12-31 | -$0.70 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-03-07 | -$2.07 10-K · filed 2024-03-07 |
| 2021-09-30 | -$0.61 10-Q · filed 2022-11-08 | -$1.01 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.37 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$0.40 10-Q · filed 2022-08-08 | -$0.76 10-Q · filed 2022-08-08 | ||
| 2020-12-31 | -$2.76 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |